This model targets the Wnt signaling pathway, which is dysregulated in approximately 30% of human gastric cancers, particularly in the genomically stable subtype, where APC mutations and β-catenin activation drive adenomatous transformation (Toshima et al., 2023; White et al., 2012). Here, APC is linked to gastric cancer.